These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 18646838)

  • 1. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
    Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides.
    Shiraishi T; Pankratova S; Nielsen PE
    Chem Biol; 2005 Aug; 12(8):923-9. PubMed ID: 16125104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
    Shiraishi T; Nielsen PE
    Nat Protoc; 2006; 1(2):633-6. PubMed ID: 17406290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates.
    Shiraishi T; Nielsen PE
    FEBS Lett; 2006 Feb; 580(5):1451-6. PubMed ID: 16460737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomolar cellular antisense activity of peptide nucleic acid (PNA) cholic acid ("umbrella") and cholesterol conjugates delivered by cationic lipids.
    Shiraishi T; Nielsen PE
    Bioconjug Chem; 2012 Feb; 23(2):196-202. PubMed ID: 22243634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
    Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
    Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal antisense effects of peptide-PNA conjugates.
    Good L; Awasthi SK; Dryselius R; Larsson O; Nielsen PE
    Nat Biotechnol; 2001 Apr; 19(4):360-4. PubMed ID: 11283595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the challenges of cellular delivery and bioavailability of peptide nucleic acids (PNA).
    Nielsen PE
    Q Rev Biophys; 2005 Nov; 38(4):345-50. PubMed ID: 16600055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular delivery of polyheteroaromate-peptide nucleic acid conjugates mediated by cationic lipids.
    Shiraishi T; Bendifallah N; Nielsen PE
    Bioconjug Chem; 2006; 17(1):189-94. PubMed ID: 16417268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
    J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavin conjugates for delivery of peptide nucleic acids.
    Marlin F; Simon P; Bonneau S; Alberti P; Cordier C; Boix C; Perrouault L; Fossey A; Saison-Behmoaras T; Fontecave M; Giovannangeli C
    Chembiochem; 2012 Nov; 13(17):2593-8. PubMed ID: 23129496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers.
    Berthold PR; Shiraishi T; Nielsen PE
    Bioconjug Chem; 2010 Oct; 21(10):1933-8. PubMed ID: 20873710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9.
    Cordier C; Boutimah F; Bourdeloux M; Dupuy F; Met E; Alberti P; Loll F; Chassaing G; Burlina F; Saison-Behmoaras TE
    PLoS One; 2014; 9(8):e104999. PubMed ID: 25127364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.